(Q45722525)

15 December 2017

title

A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype (English)

1 reference

15 December 2017

0 references

Coagulation factor VIII

0 references

0 references

0 references

Sarkar R

1

1 reference

15 December 2017

Xiao W

series ordinal

2

1 reference

15 December 2017

Kazazian HH Jr

series ordinal

3

1 reference

15 December 2017

publication date

1 February 2003

1 reference

Journal of Thrombosis and Haemostasis

15 December 2017

published in

1 reference

15 December 2017

volume

1

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

220-226

1 reference

The molecular basis of hemophilia A in man.

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Human factor VIII can be packaged and functionally expressed in an adeno-associated virus background: applicability to haemophilia A gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Partial correction of murine hemophilia A with neo-antigenic murine factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Sustained correction of bleeding disorder in hemophilia B mice by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Direct exposure of mouse spermatogenic cells to high doses of adenovirus gene therapy vector does not result in germ cell transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

Absence of germline infection in male mice following intraventricular injection of adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

An estimated frequency of endogenous insertional mutations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00096.X

10.1046/J.1538-7836.2003.00096.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference